Latest news and updates on the project.

March 2023

March 2023 – Newsletter

March 12th, 2023|

March 2023 Newsletter : More info

December 2022

December 2022 – Newsletter

December 12th, 2022|

December 2022 Newsletter: More info

September 2022

September 2022 – Newsletter

September 12th, 2022|

Sep 2022 Newsletter: More info

June 2022

June 2022 – Newsletter

June 12th, 2022|

June 2022 Newsletter : More info

August 2020

Eight Patients are now Enrolled in the ImmuoSABR Clinical Trial

August 14th, 2020|

Our trial is steadily progressing and we now have eight patients in three centres enrolled in the ImmunoSABR trial .

February 2020

First Patients Enrolled in ImmuoSABR Clinical Trial

February 3rd, 2020|

Great news the first patients have been enrolled in the ImmunoSABRclinical Trial at NKI and AZM

June 2019

METC Approval

June 2nd, 2019|

METC approval received for the centres in Maastricht, Amsterdam and Nijmegen

February 2019

Annual ImmunoSABR Meeting 2019

February 22nd, 2019|

Partners Meeting held in Amsterdam reporting on the progress of the project.

December 2018

New ImmunoSABR Website Launched

December 1st, 2018|

A new website has been designed to provide an overview of the ImmunoSABR project, its progress and information to the general public, patients and potential patients

October 2018

Presentation – Brussels & Roma

October 1st, 2018|

Professor Philippe Lambin – Immunocytokines and Radiation at the Institut Bordet, Brussels. Unconventional immunotherapy and Radiation given in Roma at the yearly national course of radiation Oncology

September 2018

Presentation – Paris

September 1st, 2018|

Professor Philippe Lambin given in Paris at the Immunorad meeting immunocytokines and radiation

August 2018

Presentation – New York

August 1st, 2018|

Professor Philippe Lambin given in New York MSKCC on Immunocytokines and radiation

July 2018

Presentation – Liverpool UK

July 1st, 2018|

Professor Philippe Lambin on Immunocytokines and Radiation given in Liverpool UK at UK Radiological Congress and Radiation and Oncology Congress (UKRCO)

June 2018

Amendment EU, Periodic report, (Ready for) Submission

June 1st, 2018|

Protocol final, ICF and patient info final, Other documents for submission final, EU amendment Part A and B final, EU Technical Report part B final, CTA final and signed, Finalizing deliverables

New Data

June 1st, 2018|

New data with three tumour models form the M-lab of precision medicine showing that immunocytokines, used in ImmunoSABR, worked better than checkpoint inhibitors with radiation.

May 2018

New Participant

May 1st, 2018|

Presentation by Professor Philippe Lambin in Antwerpen on ImmunoSABR led to them becoming a participant

April 2018

Presentation – Barcelona

April 1st, 2018|

Presentation by Professor Philippe Lambin (The M-Lab of Precision medicine) given at the ESTRO meeting in Barcelona on novel immunotherapy radiotherapy strategies Presentation by Damienne Marcus (The M-Lab of Precision medicine) given at the ESTRO meeting in Barcelona in on immunocytokines and radiation

March 2018

Presentation – Utrecht

March 1st, 2018|

Presentation by Professor Philippe Lambin given at the NVRO-NVRB meeting in Utrecht in on immunocytokines and radiation

January 2018


January 1st, 2018|

Tender (Negometrix), Submissions, Safety reporting, Risk analysis, Local monitors (visits), Training partners, Trial master file

March 2017

Kick Off Meeting – Presentation

March 1st, 2017|

First presentation was given by Professor Philippe Lambin , Brussels Kick off meeting introducing ImmunoSABR for a broad audience.

January 2017

H2020 Grant

January 1st, 2017|

H2020 grant – We received an H2020 grant from the European Union that helps us to cover the financial part for this study. We are working with a number of hospitals and centres throughout the European Union and aim to encompass patients within the whole of the EU


If you want to stay informed about ImmunoSABR project, please subscribe to our newsletter.



The D-Lab / Precision Medicine
P.O. Box 616,
6200 MD Maastricht, The Netherlands


This project has received funding from the European Union’s. Horizon 2020 research and innovation programme under grant agreement No 733008

Go to Top